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The function of the CD4 cell surface protein as 
coreceptor on T helper lymphocytes and as receptor 
for HIV makes this glycoprotein  a  prime target for 
an immune intervention with mAb. A detailed un- 
derstanding of the structural  determinants on the 
therapeutic CD4 mAb that are involved in Ag bind- 
ing or are recognized by anti-idiotypic mAb (anti-Id) 
may be important for  designing antibodies with op- 
timal therapeutic efficacy.  Seven anti-Id raised 
against the CD4 mAb M-T310 were selected from  a 
large panel with the intention to obtain CD4 mim- 
icking structures with specificity  for HIV gp120.  The 
selected anti-Id did not  react with other CDCspecific 
mAb cross-blocking M-T310. Among these, mAb M- 
T404, although having the same L chain as M-T310 
and a VH region sequence differing  only at 14 amino 
acid positions, was not recognized by the anti-Id. M- 
T310 H chain complexed  with the J558L L chain 
reacted with all anti-Id, thus demonstrating that  the 
recognized idiotopes are located within the VH re- 
gion.  To identify the idiotopes of M-T310 seen by 
the anti-Id, variants of M-T404 containing one or 
more of the M-T3 1 O-derived substitutions were  gen- 
erated by oligonucleotide-directed mutagenesis. 
The reactivity pattern of the mutant proteins with 
the anti-Id demonstrated that  the idiotopes reside 
within the complementarity determining region 
(CDR) 2 and CDR3 loops of the VH region. A major 
idiotope  was  defined by a single amino acid in CDR2 
that was  recognized by three anti-Id, whereas the 
four other anti-Id reacted with determinants of 
CDR3. Although the performed amino acid substi- 
tutions did influence the Id recognition, Ag binding 
was not significantly affected, suggesting that none 
of the anti-Id can be considered as a mimicry of the 
CD4 Ag. 
Different CD4-specific mAb, including M-T310, are 
used  either as original  mouse mAb or as chimeric mAb 
for the  treatment of various  autoimmune  diseases. It is 
not yet clear what characteristics will distinguish the 
most  efficient CD4 mAb. Furthermore,  it is not  known 
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whether and which antibodies induced in the treated 
patients will neutralize the injected CD4 antibody.  The 
V- or Ag-binding region of an antibody itself can  act as 
Ag (Id). The determinants unique to an antibody or a 
group of antibodies  referred  to as idiotopes represent  a 
three-dimensional assemblage of all residues, usually 
confined  to the CDR.3 The  experimental  induction of Id 
antibody is well established  (1,  2) and it has been directly 
associated  with the Fv fragment (3). Theoretically, anti- 
Id raised  against CD4 mAb, competing with HIV/gp 120 
for the binding  site  on the CD4 molecule, should mimic 
the CD4 receptor site  (4)  and, therefore, might be used as 
anti-idiotypic vaccine. mAb  M-T3 10, although blocking 
the HIV- 1  /rgp 120-CD4 interaction and inhibiting  infec- 
tion of susceptible cells by HIV- 1 ,4 as well as other  similar 
CD4 mAb (5, 6) did not induce anti-Id suited for anti- 
idiotype vaccine. This  apparent failure  warranted a more 
detailed analysis of the  structural  determinants, recog- 
nized by these anti-Id. 
The  structural  basis of idiotypic determinants has been 
analyzed for a number of mAb. Id located within VH 
region have been described for mAb directed against 
arsonate  (7)  and 3-fucosyllactosamine (8). The CDR3 of 
VH that includes the D segment, contributes to the Id 
determinants  in a number of antibodies  including  those 
to a( 1-3)a( 1-6)dextrans (9, lo), P( 1-6)galactan (1 1). 
phosphorylcholine (1  2). nitroiodophenyl (1 3, 14).  and p -  
azophenylarsonate (15, 16), whereas in antibodies di- 
rected to a( 1 -6)dextran.  the Id has been associated with 
the VH CDRP (17). In addition, both V and C regions of 
mAb to phosphorylcholine were required to form a  certain 
Id determinant ( 18). 
The  present  study  shows  that  the VH region of the CD4 
mAb  M-T3 10 determines  the Id reaction patterns of seven 
anti-Id. M-T404, another CD4-specific mAb possessing 
an identical VL region and a VH region differing only at 
14  amino acid positions, is not recognized by these  anti- 
Id. Several variants of M-T404 containing  one or more 
M-T3 10-derived substitutions were generated by muta- 
genesis  and expressed  together  with the M-T310 L chain. 
The  binding pattern indicates that a major Id is located 
in CDRP, recognized by three anti-Id, whereas the re- 
maining  four  anti-Id  predominantly  react  with  determi- 
nants located in CDR3. Furthermore,  none of the amino 
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acid substitutions  abolishes Ag binding and  the anti-Id 
reaction pattern is not  influenced by the C region. 
MATERIALS  AND  METHODS 
Productlon of antlbodles. mAb M-T310 and M-T404 were  raised 
against T  lymphocytes as described (19). To induce anti-Id against 
mAb M-T310, purified mAb was conjugated with keyhole limpet 
hemocyanin and mice were  immunized three  times  with  100 pg over 
a period of 2 mo. Fusions were  made and Id specific for  the  paratopic 
site of mAb M-T310 were  selected. 
Immunofluorescence. PBL were incubated with CD4 mAb and 
detection of stained cells by a FITC-conjugated antiserum  was  ana- 
lyzed using a FACScan (EPICS IV. Coulter  Electronics,  Hialah, FL). 
Histograms represent  the log of fluorescence intensity  versus cell 
number. 
biotinylated mAb M-T310. preincubated  with limiting  dilutions of 
AnaIysls of blocklng capacity of anti-Id. Aliquots of 0.1 @dm1 
anti-Id  (100 rg to 0.03 pdml) for 20 min at  room temperature, were 
incubated  with PBL at  4°C for a n  additional 20 min. Binding of M- 
T3lObio  and M-T404bio was detected by FACScan analysis  after 
FITC-conjugation with FITC-conjugated avidin. 
ELISA. To detect binding of recombinant  and  mutant Ig to  the 
anti-Id, wells of a 96-well  polystyrene  plate  were coated with  10 pg/ 
ml rabbit  anti-human IgG (Dakopatts, Glostrup, Denmark)  and 
placed at  4°C overnight. The  plates were  washed three  times with 
PBS 0.05% Tween  20. and blocked with 1% BSA in PBS for 1 h at  
room temperature.  The wells  were rinsed  three  times with Tween 
20-saline solution and  incubated  for 2 to 3 h at room temperature 
with  concentrated cell culture  supernatants,  containing 1 p g h l  of 
recombinant chimeric IgGl, followed by three  washes  with Tween 
20-saline solution. In the next step, wells were incubated  with  anti- 
Id for a n  additional  2 to 3 h at  room temperature,  washed  three  times 
with Tween 20-saline  solution,  and  binding of anti-Id to  the recom- 
binant IgG was detected by incubation  with Fc-specific peroxidase 
coupled rabbit  anti-mouse IgG serum. 
for mAb M-7’310 and  M-T404. Phage libraries  with vector EMBL3 
Clonlng of thefunctlonal  rearranged VH and  VL genes  codlng 
(Promega,  Madison, WI) were generated according to Maniatis  et al. 
(20).  Functional  rearranged V region genes  on EcoRI fragments  (2.6 
kb)  for  both H chains  and on a HtndIII fragment  (4.3  kb)  for  the L 
chain were obtained by screening  the  libraries with the probes pJ11 
(VH-specific (21)) and Jll.5 (VL-specific (22)). The functional re- 
arrangement of the obtained clones was confirmed by sequence 
analysis. dsDNA was directly sequenced using oligonucleotides 
matching the JH and J, region by the dideoxy chain termination 
method using  the  T7 polymerase sequencing kit  supplied by Phar- 
macia/LKB (Piscataway.  NJ). 
Slte-dfrected  mutagenesls. Mutagenesis of the M-T404 VH region 
was performed by polymerase chain  reaction,  using a modified pro- 
cedure as described by Nelson et al.  (23). Briefly, DNA containing 
the M-T404 VH region was amplified in two cycles: In the  first cycle. 
two fragments were produced by elther  using a 5‘-specific oligo (A: 
located in the 5’ untranslated region, S’GGTCGACGAATTCCTGAA 
CACACACTGAC 3 ‘  with an EcoRI restriction site)  and  the oligo 
containing  the  mutation as the  3‘ primer (B). or an oligonucleotide 
with  the  mutation as the  5’ primer (C) and a JH/intron  specific 3’ 
oligonucleotide with a NotI restriction site ID, 5’ CCAGCGGCCGCG 
GACTCACCTGCCAGCGAC 3’).  The two fragments  containing an 
overlap of I 5  to 20 nucleotfdes  were  purified from agarose gel. fused. 
and  further amplified by the A and D oligonucleotides. The obtained 
VH fragments were digested with EcoRI and NotI, and subcloned into 
the expression vector. The introduced mutations were verified by 
DNA sequence  analysis. 
Oligonucleotides B and C  for  site-directed mutagenesis  in 5’- 3’ 
orientation: 
h l -  1 : B: ACTTACAACATAATCAGTGAATGTG: C:  ACTGAC- 
TATGTTGTAAGTTGGATG: 
GAGAAAT: 
C:GGTTCCCTCGGGTTTGCTCACTGG; 
h3-2: 8: CCCGAGGGAACCATCTCCTCGCCTTGCACAG: C: a s  h3- 1 
h2- 1 : B: CATTGTAGTACGAACTACCACTTC: C:  GCTTACTACAAT- 
h3-  1 : B: GTGAGCAAACCCGAGGGAACCCTGTCCTGACCTTGCAC; 
c-01igo; 
h9-  1 : B: CTGCAGTCAGTGTGGCCTTGCCC: C:  GGCCACACT- 
GACTGCAGACAAATC. 
Expresslon vectors. The  7.0 kb-EcoRIIBamHI fragment  contain- 
ing  the  exons coding for  the  human lgGl C region, has been sub- 
cloned into  the vector pSVgpt (24). After  introduction of a NotI linker 
5’ of the EcoRI site,  the Ig enhancer on a 1.9-kb NotllEcoRI fragment 
has been  introduced. The EcoRI site between enhancer  and C region 
was destroyed by trimming  with  T4 DNA polymerase and  blunt  end 
ligation. Then  the  2.2-kb EcoRI/NotI fragment of the vector pcDNAI 
(British/Bio-technology, Oxford, UK) containing  the  sup F region, the 
CMV promoter, and  its polylinker has been  subcloned by replacing 
the PvuI/NotI fragment of the pSVgpt vector. Thus this vector 
(CMVh-1) allowed subcloning of polymerase chain reaction frag- 
the EcoRI and NotI site. 
ments  generated by the  primers A and D. as  described  above, into 
For the L chain, the 4.3-kb HlndlII fragment, Containing the 
functional  rearranged VL region, was blunt-ended as  the Sal1 cloning 
site of pSV2-neo vector and ligated. This vector contains  the  human 
C region gene  on a 4.6-kb SalIIBamH I fragment. 
Transfection assays.  Transfection of actively growing P3.X63.- 
Ag8.653 and J558L mouse myeloma cells was carried  out by electro- 
poration using a Bio-Rad Laboratories  (Richmond, CA) gene  pulser 
following the recommendations of the  supplier. 
RESULTS 
Inhibition of CD4 Ag binding by  anti-ld. As part of the 
characterization of the  interactions between anti-Id and 
mAb M-T310 and M-T404, the ability of anti-Id  to  inhibit 
binding of mAb to the Ag CD4 on PBL was  determined by 
FACScan (Coulter) analysis. All anti-Id  generated  against 
mAb M-T310 blocked CD4-binding activity of mAb M- 
T310 (Fig. 1A) and  they did not  react  with mAb  M-T404 
(Fig. 1B). 
CD4 Ag binding of the recombinant lg .  The deduced 
amino acid sequences of the M-T3 10  (h310-  1)  and M- 
T404  (h404-1) VH regions and  their mutated variants  are 
shown in Figure 2. Although generated from different 
mice, both mAb have identical L chains.  Transfection of 
the  constructs  h310- 1 and  h404-1 containing the chi- 
meric H chain genes together with the chimeric L chain 
gene  resulted  in the expression of recombinant Ig with 
CD4 specificity as shown  in Figure 3. Transfection of the 
H chain  construct  h310-1  into  the cell line J558L (ex- 
pressing a lambda L chain,  but no H chain) also led to 
the expression of a  chimeric Ig J h 3  10-  1  with CD4 speci- 
ficity. The mutated M-T404 VH chains also showed a 
normal distribution of CD4 positive T lymphocytes by 
staining PBL (Fig. 3) .  A s  none of the introduced mutations 
abolished CD4 Ag binding, it seems  that  the exchanged 
amino  acids are not decisive for Ag binding. Furthermore, 
Ag specificity is determined by the H chain, as the CD4 
Ag binding specificity can be preserved by the combina- 
tion of the M-T310 H chain  and  the 5558 X L chain. 
Anti-Id binding pattern of the mutated lg. mAb M- 
T404 did not  react  neither as murine mAb nor as chi- 
meric mAb (h404-1) with the analyzed anti-Id, which 
recognized the mAb M-T310 used as immunogen as well 
as its chimeric  counterpart h310-1 (Fig. 4). A virtually 
identical reactivity was observed with mAb JX3 10- 1 (M- 
T310 VH chain  and  5558 lambda L chain),  thus demon- 
strating  that all idiotopes recognized are determined by 
the V, region with no obvious interference by the L chain. 
The exchange of amino acid 34 Iie-Val (hl  - I ) ,  the only 
difference  within CDRl between M-T310 and M-T404, 
did not lead to  a  measurable binding of any anti-Id. In 
contrast, a major idiotope appears to be  determined by 
amino acid 58,  the only difference  within CDR2 of the 
two antibodies. The exchange of Asn to Ala (h2- 1) recon- 
stituted binding reactivity with anti-Id 21 -48, 20-02, 
and 20-26. Also the recombinant Ig h9-1,  a hybrid be- 
tween M-T310 and M-T404 H chains  retaining CDR3 of 
M-T404, showed an identical reactivity pattern as h2- 1. 
The  results  indicate  that CDR 1 appears not to  be  involved 
in the binding reactivity of the anti-Id. A s  M-T404 differs 
from M-T3 10 by four closely linked amino  acids in CDR3, 
site-directed mutations  within  this region were of consid- 
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binding of M-T3lObio ( A )  and M-T404bio 
Figure 1 .  Capacity of anti-ld to block 
[B) to Ag  CD4  of PBL. The blocking capac- 
channel a s  determined by FACScan [Coul- 
ity is shown as the reduction of mean 
ter)  analysis.  The anti-Id 23-54 was 
raised against mAb M-T 1 5 1 and  serves as 
negative control. 0 c 
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80 
h3-1 : ...... .T--...--Q-...--.y.. 
h3-2 : ...... .-T-...--.Q.-..--..~.. 
h9-1 : ...... --~-.....----..p.-."------y---- 
h404-1: ...... --T....------..Q..----.....~---- ........ 7 CUR3 
Ftgure 2. Deduced amino acid sequences of VH regions of natlve and 
residues are numbered  consecutively. The location of  CDR are indicated 
mutant mAb analyzed for anti-Id binding reactivity. The amino acid 
in frames. The symbol (-1 corresponds to the same amino acid as in 
sequence h3 10- 1 and 1.) marks a deletion. 
erable  interest. In mAb h3- 1, we inserted  amino acid Gly 
102  and  amino acid Ser  103  present  in mAb  M-T3 10,  but 
no  reactivity  with any of the anti-Id was observed. The 
complete exchange of CDR3 between M-T310 and M- 
T404 (h3-2) led to  the binding of anti-Id  20-46,  20-58, 
(concentration of blocking anti-Id, pgiml) 
20-33, and 20-45. Moreover, a distinct, albeit weak, 
binding reactivity was observed with  anti-Id mAb 2 1-48, 
20-02. and 20-26 recognizing the idiotope in CDR2. 
Thus, determinants within CDR3 may directly be in- 
volved as contact  sites  in  the interaction  with these  anti- 
Id. Differences within the framework regions of M-T3 10 
and M-T404 apparently  have  no effect on the binding of 
anti-Id. 
DISCUSSION 
The  structural  basis for the anti-Id  binding ability of 
two closely related CD4  mAb  M-T3 10  and M-T404 was 
investigated. Variants of M-T404 H chain  that  contain 
single  or combined M-T310 VH substitutions were gen- 
erated by oligonucleotide-directed mutagenesis followed 
by expression of mutant proteins  containing  the M-T3 1 O/ 
M-T404 (identical L chain) L chain.  The mutated M-T404 
V, chains showed a  normal  distribution of CD4' T lym- 
phocytes by staining PBL. A s  none of the introduced 
mutations  abolished CD4 Ag binding, it seems that  the 
exchanged  amino  acids are not decisive for Ag binding. 
Furthermore,  the combination of the M-T3 10-specific H 
chain  and  the X L chain of the J558L cell line  resulted in 
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Figure3. FACS analysis with chi- E a 
meric I& PBL were incubated with the = 
indicateb Ig and stained with FITC-anti- 8 
negative and CD4 positive cells is shown 
as two peaks. - OI 
human IgG serum. The distribution of a hl-1 h3-1 
Log fluorescence  intensity 
h404-1 
h l - 1  
h2-1 
h3-1 
different VH region constructs shown In Figure 1 .  The binding reactivity 
Figure 4. Comparative representation of anti-Id reactivity with the 
was measured by  ELISA as described. The determined OD was valued as 
follows: OD < 0.3, no binding activity [whfte  boxes: measured cross- 
reactivity of POX antiserum with any human IgG antibody); OD 0.4 to 
0.6. weak binding activity [gray boxes): OD > 0.6. binding actlvity 
marked wlth black boxes: anti-Id 23-54 as  negative control was raised 
against mAb M-T151 which recognizes a different epitope on the CD4 
molecule. 
an Ig with CD4 Ag-binding specificity. This result is 
consistent  with  earlier  data  demonstrating that VH chains 
can be expressed  together  with any L chain  (25) without 
losing their Ag specificity. Moreover, it has been shown 
that VH domains  alone  are  able to bind Ag (26). In all 
these  cases,  the VH region predominantly  contributed to 
Ag-binding specificity. 
The combination of the M-T310 H chain  and  the X L 
chain 5558 clearly shows that  the reactivity of all  seven 
anti-Id is associated  with the H chain. "T310-derived 
substitutions in the M-T404 H chain by mutagenesis 
analysis  show  that  the anti-Id react  with idiotopes deter- 
mined by CDRP and CDR3. The  conservative  exchange 
in CDRl (Ile-Val; hl-1) had  no  effect  on  anti-Id  binding, 
whereas  the single substitution  in CDR2 (Asn -Ala; h2- 
1)  restores  binding of three anti-Id. 
The observations that single substitutions  in CDR2 and 
CDR3 can profoundly affect idiotypic specificity has been 
observed in several  systems (13, 16,  17). As  has also  been 
described in these  studies,  the  exchange of amino  acids 
involved in recognition by anti-Id did not  affect Ag bind- 
ing. Thus, major idiotopes appear  not  to be involved in 
Ag binding or play no important role. A s  CDR3 of M- 
T3  10  and M-T404 H chains do not only differ in  sequence 
but also  in  length, the  substitution of Ser  to Arg (position 
99) and Gln to Asp (position 101)  in  the  construct h3-1 
does not restore anti-Id binding. Only the additional 
lengthening of CDR3  by insertion of  Gly and  Ser (position 
102,  103)  in  the h3-2 construct  reconstituted the idiotope 
recognized  by four anti-Id. The involvement of all  four 
exchanged residues does not necessarily mean direct 
binding between these  residues and  the anti-Id,  but could, 
alternatively,  mean that some of these  residues indirectly 
affect  binding by changing the conformation of the CDR3 
loop. The differences in the length most certainly lead to 
different  three-dimensional structures in the CDR3  loop 
regions of mAb  M-T3 10  and M-T404. 
The network theory of idiotope-anti-idiotope interac- 
tions (4, 27, 28) includes anti-Id that are the internal 
image of Ag. The  binding of such anti-Id to their idiotopes 
is inhibited by Ag. A subdivision into two groups of Ag- 
inhibitable  anti-Id has been proposed (29, 30): those that 
mimic an antigenic structure and those that do not. 
Although the binding of all anti-Id is Ag-inhibitable, we 
conclude from the presented data  that  the analyzed anti- 
Id do not  react  with the paratope of M-T310 and fail to 
mimic the  internal image of the Ag CD4. They fall into 
the second group of anti-Id according to the above clas- 
sification and do not bear  conformational  resemblance 
to the Ag CD4. This may be because of the  fact that M- 
T310  and also M-T404 do not bind CD4 in  the  same way 
as gp120,  although  they efficiently block the HIVl/CD4- 
interaction. Our results  are also confirmed by failure of 
these anti-Id to bind HIV/gp120. Although we did not 
analyze possible changes in affinity  caused by the  sub- 
stitutions,  staining of  PBL by the mutated  proteins indi- 
cates  that residues involved in anti-Id binding and Ag 
binding differ from each  other. 
It has been suggested that receptors that  share  the Ig 
fold, may provide more favorable  targets for anti-Id mim- 
icry (31). M-T310 and M-T404 recognize the CDR2-like 
region in  domain  1 of  CD4 which resembles very closely 
the V domain of Ig (32, 33). The conformation of  CDR2 
analog of  CD4 differs from that of Ig as it is extended by 
three amino acids in comparison to the Bence-Jones 
protein REI VL domain.  Particularly, the CDR2-like  loop 
juts out at  the  tip of the D l  domain,  creating a prominent 
ridge. This structure might hinder anti-Id antibody to 
provide exact images of the  external CD4 Ag. A previously 
published study  (34) described the detection of a  cross- 
reactive idiotope on CD4  mAb  Leu 3a and ascribed this 
reactivity to the L chain. A s  in our CD4 system, the  anti- 
Id induced against mAb  Leu 3a failed to bind gp120. But 
in  contrast  to  the presented data,  these anti-Id showed 
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cross-reactivity with different other CD4 mAb with a 
similar  reactivity  pattern. We could not  find  cross-reac- 
tivity of the analyzed  anti-Id  with  other CD4 mAb that 
are supposed to recognize the  same or an overlapping 
epitope on the CD4 molecule, although  the used V regions 
of these  antibodies  are closely related (see footnote 4). 
The presence of L chain-associated idiotopes in  our sys- 
tem is not excluded, but we selected for  anti-Id that  are 
able to inhibit  binding of  CD4 mAb to CD4.  In our  system, 
the CD4 Ag binding of M-T310. as well as of M-T404, is 
exclusively determined by the H chain.  The Ag specificity 
of  CD4 mAb  Leu 3a and related mAb might be determined 
mainly by the L chain V region, thus leading  to  a selection 
of L chain-specific anti-Id. The  failure  to  detect  cross- 
reactive anti-Id upon immunization with mAb M-T310 
cannot be explained by the  presented  data. 
By using  mouse/human  chimeric Ig. we demonstrate 
that,  at least in the presented system, anti-Id binding 
reactivity is independent of the isotype and not influ- 
enced by the C region as stated to be required to form a 
correct idiotypic determinant on  phosphorylcholine-spe- 
cific antibody (18). Furthermore,  the  finding  that a single 
amino acid substitution  renders an  antibody  essentially 
invisible for  a  variety of anti-Id might be of importance 
for the regulation of the antibody  response,  because an 
exchange induced by somatic  mutation would easily al- 
low escape  from Id control (4). A practical  application of 
this work has  arisen from the  current  use of CD4 mAb 
as therapeutic  agents  in  chronic  autoimmune  diseases, 
where  repeated  administrations are  necessary, with the 
consequence that  the treated  patients produce neutral- 
izing anti-Id (35). To circumvent this effect, the possibil- 
ity of selecting  non-cross-reactive idiotopes would be of 
great  advantage. 
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